{"id":"https://openalex.org/W4237570064","doi":"https://doi.org/10.1200/jco.2005.03.2318","title":"In Reply:","display_name":"In Reply:","publication_year":2005,"publication_date":"2005-10-28","ids":{"openalex":"https://openalex.org/W4237570064","doi":"https://doi.org/10.1200/jco.2005.03.2318"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2005.03.2318","doi":"https://doi.org/10.1200/jco.2005.03.2318","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2005.03.2318","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.03.2318?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.03.2318?role=tab","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023226233","display_name":"Michael P. DiGiovanna","orcid":"https://orcid.org/0000-0002-4902-3196","observed_orcids":["https://orcid.org/0000-0002-4902-3196"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael P. DiGiovanna","raw_affiliation_strings":["Yale Medical School, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Medical School, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009455412","display_name":"David F. Stern","orcid":"https://orcid.org/0000-0003-4018-5348","observed_orcids":["https://orcid.org/0000-0003-4018-5348"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David F. Stern","raw_affiliation_strings":["Yale Medical School, New Haven, CT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale Medical School, New Haven, CT","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108527484","display_name":"Susan M. Edgerton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan M. Edgerton","raw_affiliation_strings":["University of Oklahoma Health Sciences Center, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma Health Sciences Center, Oklahoma City, OK","institution_ids":["https://openalex.org/I49332381"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013400628","display_name":"Ann D. Thor","orcid":"https://orcid.org/0000-0001-7725-1869","observed_orcids":["https://orcid.org/0000-0001-7725-1869"]},"institutions":[{"id":"https://openalex.org/I49332381","display_name":"University of Oklahoma Health Sciences Center","ror":"https://ror.org/0457zbj98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I49332381"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann D. Thor","raw_affiliation_strings":["University of Oklahoma Health Sciences Center, Oklahoma City, OK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Oklahoma Health Sciences Center, Oklahoma City, OK","institution_ids":["https://openalex.org/I49332381"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"23","issue":"31","first_page":"8119","last_page":"8120"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.6399999856948853},{"id":"https://openalex.org/keywords/erbb2","display_name":"ERBB2","score":0.949999988079071},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6990000009536743},{"id":"https://openalex.org/keywords/antibody-cross-reactivity","display_name":"antibody cross-reactivity","score":0.8379999995231628},{"id":"https://openalex.org/keywords/immunohistochemistry","display_name":"immunohistochemistry","score":0.7329999804496765},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.6019999980926514},{"id":"https://openalex.org/keywords/skbr-3-cells","display_name":"SK-BR-3 cells","score":0.8370000123977661},{"id":"https://openalex.org/keywords/mcf-10a-cells","display_name":"MCF10A cells","score":0.9089999794960022},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.5180000066757202},{"id":"https://openalex.org/keywords/her2-amplification","display_name":"HER2 amplification","score":0.5379999876022339},{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.3160000145435333},{"id":"https://openalex.org/keywords/her3","display_name":"HER3","score":0.3959999978542328},{"id":"https://openalex.org/keywords/erbb4","display_name":"ErbB4","score":0.7760000228881836},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.37700000405311584},{"id":"https://openalex.org/keywords/her2-negative-breast-cancer","display_name":"HER2-negative breast cancer","score":0.4480000138282776}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8349066972732544}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2005.03.2318","doi":"https://doi.org/10.1200/jco.2005.03.2318","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2005.03.2318","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.03.2318?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1200/jco.2005.03.2318","doi":"https://doi.org/10.1200/jco.2005.03.2318","is_oa":true,"landing_page_url":"https://doi.org/10.1200/jco.2005.03.2318","pdf_url":"https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.03.2318?role=tab","source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308380","display_name":"Yale University","ror":"https://ror.org/03v76x132"},{"id":"https://openalex.org/F4320337612","display_name":"Yale Liver Center","ror":null}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4237570064.pdf","grobid_xml":"https://content.openalex.org/works/W4237570064.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W1974868313","https://openalex.org/W2007435673","https://openalex.org/W2028115459","https://openalex.org/W2112311127","https://openalex.org/W2158077354"],"related_works":["https://openalex.org/W2329833730","https://openalex.org/W2045220494","https://openalex.org/W2016768188","https://openalex.org/W2015618811","https://openalex.org/W7099307523","https://openalex.org/W2086080480","https://openalex.org/W2056793446","https://openalex.org/W3184133907","https://openalex.org/W1966032275","https://openalex.org/W2025307506"],"abstract_inverted_index":{"vector,":[0],"EGFR,":[1],"or":[2,83],"increasing":[3],"amounts":[4,63],"of":[5,64,75,121,134,173,191,210,228,235,378,449,464],"ErbB-2":[6,65,86,127,136,236,286,326,406,414,424,430,450,461],"plasmid":[7,35,66],"(Fig":[8,36,67,98,300,321,342],"1A,":[9,37,68,99,150],"lanes":[10,71,104,152],"4":[11,105],"to":[12,73,106,139,248,493],"8).As":[13,107],"in":[14,30,57,143,156,178,238,242,256,383,408,442,477,485],"the":[15,20,26,58,79,85,91,95,110,113,118,122,140,144,164,175,179,192,211,219,233,239,243,262,279,350,355,358,369,390,395,412,435,460,465,483,486],"breast":[16,114,386,478],"cancer":[17,115],"cell":[18,116,146,264],"lines,":[19,117],"anti-EGFR":[21,80,123,165,212,280,291,307,359,370,466,509],"(1005)":[22,124,166,213,281,292,360,371,467],"antibody":[23,82,88,125,167,193,282,293,308,328,372,468],"used":[24,288],"by":[25,109,181,397,488],"authors":[27,201],"detected":[28],"EGFR":[29,34,56,391,418,440,454,476],"cells":[31,59,93,299,316,320,341],"transfected":[32,60,92,135],"with":[33,61,78,84,112,126,163,214,271,285,349,375,385,411,429,496,505],"panel":[38,69],"1,":[39,70],"lane":[40],"5)":[41],"as":[42,44,177,404],"well":[43],"a":[45,50,187,257,269,305,473,506],"protein":[46],"that":[47,90,205,218,232,368,423,482,499],"migrates":[48],"at":[49,131,225],"slightly":[51],"higher":[52],"molecular":[53],"weight":[54],"than":[55,417,453],"high":[62,132,226,376],"6":[72],"8).Reprobing":[74],"this":[76,388,443],"blot":[77],"(2232)":[81],"specific":[87,327,508],"confirmed":[89,504],"expressed":[94],"appropriate":[96],"proteins":[97],"panels":[100,157],"2":[101],"and":[102,154,159,273,297,364,426,433,498],"3,":[103],"suggested":[108],"data":[111,216,346,366,393,484],"cross":[119,196,208,220,250,254,283,351,373,462],"reactivity":[120,197,209,221,255,352,463],"was":[128],"only":[129,223],"seen":[130,142,353,382],"levels":[133,227,377,380,432,451],"expression":[137,141,392,407,415,431,441],"comparable":[138],"SKBr3":[145,263,298,319],"line":[147,265],"(eg,":[148],"Fig":[149],"compare":[151],"3":[153],"7":[155],"1":[158],"3).Our":[160],"immunoblotting":[161,363],"experiments":[162],"were":[168],"performed":[169],"using":[170,186],"0.2":[171],"g/mL":[172],"antibody,":[174],"same":[176],"paper":[180,244,396,487],"DiGiovanna":[182,398,489],"et":[183,399,490],"al.Additional":[184],"experiments,":[185],"10-fold":[188],"lower":[189,344],"dilution":[190],"showed":[194],"similar":[195],"(data":[198],"not":[199,246,318,339,470],"shown).The":[200],"show":[202,217],"an":[203,325,447],"immunoblot":[204,356],"demonstrates":[206],"no":[207],"ErbB-2.Our":[215],"is":[222,230,245,266],"apparent":[224],"ErbB-2.It":[229],"possible":[231],"amount":[234],"precipitated":[237],"experiment":[240],"shown":[241],"sufficient":[247],"elicit":[249],"reactivity.However,":[251],"we":[252,480],"observe":[253],"physiologically":[258],"relevant":[259],"context":[260],"since":[261],"derived":[267],"from":[268,310,330,394,439],"patient":[270],"amplified":[272],"overexpressed":[274],"ErbB-2.We":[275],"next":[276],"tested":[277],"whether":[278],"reacted":[284],"when":[287],"for":[289,357,475],"immunohistochemistry.The":[290],"stained":[294,314,335],"both":[295],"MCF10A":[296,315,340],"1B,":[301,322,343],"top":[302],"panels).In":[303],"contrast,":[304],"second":[306],"(31G7":[309],"Zymed,":[311],"Carlsbad,":[312],"CA)":[313,334],"but":[317,338],"middle":[323],"panels).Similarly,":[324],"(CB11":[329],"Biogenex,":[331],"San":[332],"Ramon,":[333],"SkBr3":[336],"cells,":[337],"panels).These":[345],"are":[347],"consistent":[348],"on":[354],"antibody.Together,":[361],"our":[362,457],"immunohistochemistry":[365],"suggest":[367],"reacts":[374],"ErbB-2,":[379],"frequently":[381],"patients":[384,410],"cancer.In":[387],"light,":[389],"al":[400,491],"could":[401,445],"be":[402,446,494,503],"interpreted":[403,495],"detecting":[405],"those":[409],"highest":[413],"rather":[416,452],"coexpression.Previous":[419],"work":[420],"has":[421],"demonstrated":[422],"activation":[425],"prognosis":[427],"correlate":[428],"thus":[434],"prognostic":[436],"information":[437],"gained":[438],"article":[444],"indication":[448],"coexpression.3":[455],"While":[456],"observations":[458,501],"about":[459],"do":[469],"rule":[471],"out":[472],"role":[474],"cancer,":[479],"feel":[481],"need":[492],"caution":[497],"their":[500],"should":[502],"more":[507],"antibody.":[510]},"counts_by_year":[],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2022-05-12T00:00:00"}